Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: Crossy who wrote (265)	10/13/2001 5:24:57 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 724

>> turnaround completed << Yeah, yeah, rub it in....... I've been watching you in this dog, Harmon, waiting for the correct time to enter. <vpg> I still think that they just plain weren't prepared for the funding window that opened 11/99. With a little foresight, I sincerely believe that they could have been in this situation, 4/00. Sigh. Well...... I feel that this is one of the very best bioterrorism plays. They should be square in the sweet spot, with a company worth $15-20/share given only existing business. There are gazillions of wimp shareholders waiting to get out. We need volume, demand to drive us through them. It could come from recognition as a trickle play on bioterror, from another DGI funding, or from the next quarterly? I will not sell a single share south of double digits. That's a promise. If someone bails into early demand, it will not be me.